{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:49:54Z","timestamp":1792612194985,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/mp.2015.206","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T09:00:40Z","timestamp":1452589240000},"page":"1351-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":219,"title":["Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-1116","authenticated-orcid":false,"given":"E","family":"Haroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C C","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Woolwine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X P","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"key":"BFmp2015206_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL . Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.biopsych.2013.03.032","volume":"73","author":"G Sanacora","year":"2013","unstructured":"Sanacora G, Banasr M . From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013; 73: 1172\u20131179.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M . Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62: 63\u201377.","journal-title":"Neuropharmacology"},{"key":"BFmp2015206_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YCO.0b013e32835aa4b4","volume":"26","author":"L Stertz","year":"2013","unstructured":"Stertz L, Magalhaes PV, Kapczinski F . Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 2013; 26: 19\u201326.","journal-title":"Curr Opin Psychiatry"},{"key":"BFmp2015206_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","volume":"69","author":"L Capuron","year":"2012","unstructured":"Capuron L, Pagnoni G, Drake D, Woolwine B, Spivey J, Crowe R et al. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 2012; 69: 1044\u20131053.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2015206_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.biopsych.2007.12.007","volume":"63","author":"L Brydon","year":"2008","unstructured":"Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD . Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008; 63: 1022\u20131029.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/mp.2008.58","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH . Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 2010; 15: 535\u2013547.","journal-title":"Mol Psychiatry"},{"key":"BFmp2015206_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR . Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 2010; 68: 748\u2013754.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD . Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009; 66: 407\u2013414.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.biopsych.2009.03.007","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Dolan RJ et al. Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 2009; 66: 415\u2013422.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70: 31\u201341.","journal-title":"JAMA Psychiatry"},{"key":"BFmp2015206_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29\u201335.","journal-title":"Lancet"},{"key":"BFmp2015206_CR14","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1200\/JCO.2005.04.2838","volume":"24","author":"JP Monk","year":"2006","unstructured":"Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 2006; 24: 1852\u20131859.","journal-title":"J Clin Oncol"},{"key":"BFmp2015206_CR15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1038\/sj.npp.1301387","volume":"32","author":"MA Frye","year":"2007","unstructured":"Frye MA, Watzl J, Banakar S, O'Neill J, Mintz J, Davanzo P et al. Increased anterior cingulate\/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007; 32: 2490\u20132499.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pscychresns.2013.02.008","volume":"213","author":"J Xu","year":"2013","unstructured":"Xu J, Dydak U, Harezlak J, Nixon J, Dzemidzic M, Gunn AD et al. Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res 2013; 213: 235\u2013241.","journal-title":"Psychiatry Res"},{"key":"BFmp2015206_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","volume":"68","author":"C Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel C, \u00d6ng\u00fcr D . Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 2010; 68: 785\u2013794.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/npp.2009.2","volume":"34","author":"SJ Yoon","year":"2009","unstructured":"Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF . Decreased glutamate\/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2009; 34: 1810\u20131818.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR19","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M . Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 2007; 62: 1310\u20131316.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000347090","volume":"67","author":"JR Strawn","year":"2013","unstructured":"Strawn JR, Chu WJ, Whitsel RM, Weber WA, Norris MM, Adler CM et al. A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder. Neuropsychobiology 2013; 67: 224\u2013229.","journal-title":"Neuropsychobiology"},{"key":"BFmp2015206_CR21","first-page":"832","volume":"21","author":"M Castillo","year":"2000","unstructured":"Castillo M, Kwock L, Courvoisie H, Hooper SR . Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol 2000; 21: 832\u2013838.","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFmp2015206_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.euroneuro.2015.04.016","volume":"25","author":"D Arnone","year":"2015","unstructured":"Arnone D, Mumuni AN, Jauhar S, Condon B, Cavanagh J . Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: Meta-analysis of absolute prefrontal neuro-metabolic concentrations. Eur Neuropsychopharmacol 2015; 25: 1109\u20131117.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp2015206_CR23","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/sj.npp.1301248","volume":"32","author":"O Ajilore","year":"2007","unstructured":"Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 2007; 32: 1224\u20131231.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","volume":"62","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N, Liu RJ, Duric V, Aghajanian G . Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012; 62: 35\u201341.","journal-title":"Neuropharmacology"},{"key":"BFmp2015206_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351\u2013354.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","volume":"67","author":"M aan het Rot","year":"2010","unstructured":"aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 2010; 67: 139\u2013145.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/jnr.21325","volume":"85","author":"S Tilleux","year":"2007","unstructured":"Tilleux S, Hermans E . Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 2007; 85: 2059\u20132070.","journal-title":"J Neurosci Res"},{"key":"BFmp2015206_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2007.12.047","volume":"432","author":"T Ida","year":"2008","unstructured":"Ida T, Hara M, Nakamura Y, Kozaki S, Tsunoda S, Ihara H . Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett 2008; 432: 232\u2013236.","journal-title":"Neurosci Lett"},{"key":"BFmp2015206_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/glia.20275","volume":"53","author":"C Matute","year":"2006","unstructured":"Matute C, Domercq M, Sanchez-Gomez MV . Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006; 53: 212\u2013224.","journal-title":"Glia"},{"key":"BFmp2015206_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuint.2007.06.005","volume":"52","author":"E Malarkey","year":"2008","unstructured":"Malarkey E, Parpura V . Mechanisms of glutamate release from astrocytes. Neurochem Int 2008; 52: 142\u2013154.","journal-title":"Neurochem Int"},{"key":"BFmp2015206_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-014-1187-1","volume":"121","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Walker A . Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) 2014; 121: 925\u2013932.","journal-title":"J Neural Transm (Vienna)"},{"key":"BFmp2015206_CR32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H . Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010; 11: 682\u2013696.","journal-title":"Nat Rev Neurosci"},{"key":"BFmp2015206_CR33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/npp.2014.25","volume":"39","author":"E Haroon","year":"2014","unstructured":"Haroon E, Woolwine BJ, Chen X, Pace TW, Parekh S, Spivey JR et al. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology 2014; 39: 1777\u20131785.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbi.2014.12.004","volume":"46","author":"E Haroon","year":"2015","unstructured":"Haroon E, Felger JC, Woolwine BJ, Chen X, Parekh S, Spivey JR et al. Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: preliminary findings. Brain Behav Immun 2015; 46: 17\u201322.","journal-title":"Brain Behav Immun"},{"key":"BFmp2015206_CR35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/npp.2013.71","volume":"38","author":"AK Walker","year":"2013","unstructured":"Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders B et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6\u2009J mice. Neuropsychopharmacology 2013; 38: 1609\u20131616.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","volume":"4","author":"R Schwarcz","year":"2004","unstructured":"Schwarcz R . The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol 2004; 4: 12\u201317.","journal-title":"Curr Opin Pharmacol"},{"key":"BFmp2015206_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CE, Alves LB, Porciuncula LO, Emanuelli T et al. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 2002; 40: 621\u2013627.","journal-title":"Neurochem Int"},{"key":"BFmp2015206_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","volume":"38","author":"S Erhardt","year":"2013","unstructured":"Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D, Samuelsson M et al. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 2013; 38: 743\u2013752.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/npp.2014.194","volume":"40","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Smith CM, Victor TA, Wurfel BE, Bellgowan PS et al. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 2015; 40: 463\u2013471.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno D, Kivimaki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009; 39: 413\u2013423.","journal-title":"Psychol Med"},{"key":"BFmp2015206_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171\u2013186.","journal-title":"Psychosom Med"},{"key":"BFmp2015206_CR42","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. (SCID-IV)","author":"MB First","year":"2002","unstructured":"First MB, Spitzer RL, Gibbon M, JBW Williams . Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. (SCID-IV). Biometrics Research, New York State Psychiatric Institute: New York, 2002."},{"key":"BFmp2015206_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFmp2015206_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR . \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189\u2013198.","journal-title":"J Psychiatr Res"},{"key":"BFmp2015206_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"MH Trivedi","year":"2004","unstructured":"Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34: 73\u201382.","journal-title":"Psychol Med"},{"key":"BFmp2015206_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1755-5949.2009.00102.x","volume":"16","author":"GM Chandler","year":"2010","unstructured":"Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M . RESEARCH: validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther 2010; 16: 322\u2013325.","journal-title":"CNS Neurosci Ther"},{"key":"BFmp2015206_CR47","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.7717\/peerj.429","volume":"2","author":"R Ameli","year":"2014","unstructured":"Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED et al. SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration. PeerJ 2014; 2: e429.","journal-title":"PeerJ"},{"key":"BFmp2015206_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3758\/BF03212238","volume":"51","author":"CE Collyer","year":"1992","unstructured":"Collyer CE, Broadbent HA, Church RM . Categorical time production: evidence for discrete timing in motor control. Percept Psychophys 1992; 51: 134\u2013144.","journal-title":"Percept Psychophys"},{"key":"BFmp2015206_CR49","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbi.2007.12.009","volume":"22","author":"M Majer","year":"2008","unstructured":"Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH . IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 2008; 22: 870\u2013880.","journal-title":"Brain Behav Immun"},{"key":"BFmp2015206_CR50","first-page":"399","volume":"85","author":"BJ Sahakian","year":"1992","unstructured":"Sahakian BJ, Owen AM . Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992; 85: 399\u2013402.","journal-title":"J R Soc Med"},{"key":"BFmp2015206_CR51","volume-title":"Wechsler Adult Intelligence Test","author":"D Wechsler","year":"2008","unstructured":"Wechsler D, Coalson D, Raiford S . Wechsler Adult Intelligence Test Fourth Edition Technical and Interpretative Manual Pearson: San Antonio, 2008."},{"key":"BFmp2015206_CR52","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993; 30: 672\u2013679.","journal-title":"Magnetic Resonance in Medicine"},{"key":"BFmp2015206_CR53","first-page":"321","volume":"25","author":"A Gussew","year":"2012","unstructured":"Gussew A, Erdtel M, Hiepe P, Rzanny R, Reichenbach JR . Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in (1)H-MR spectroscopic volumes. Magma (New York, NY) 2012; 25: 321\u2013333.","journal-title":"Magma (New York, NY)"},{"key":"BFmp2015206_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.02.014","volume":"111","author":"MH Hall","year":"2015","unstructured":"Hall MH, Jensen JE, Du F, Smoller JW, O'Connor L, Spencer KM et al. Frontal P3 event-related potential is related to brain glutamine\/glutamate ratio measured in vivo. Neuroimage 2015; 111: 186\u2013191.","journal-title":"Neuroimage"},{"key":"BFmp2015206_CR55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/jmri.23945","volume":"37","author":"S Posse","year":"2013","unstructured":"Posse S, Otazo R, Dager SR, Alger J . MR spectroscopic imaging: principles and recent advances. J Magn Reson Imaging 2013; 37: 1301\u20131325.","journal-title":"J Magn Reson Imaging"},{"key":"BFmp2015206_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/clpt.2009.255","volume":"87","author":"MF O'Connor","year":"2010","unstructured":"O'Connor MF, Irwin MR . Links between behavioral factors and inflammation. Clin Pharmacol Ther 2010; 87: 479\u2013482.","journal-title":"Clin Pharmacol Ther"},{"key":"BFmp2015206_CR57","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL . CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013; 150: 736\u2013744.","journal-title":"J Affect Disord"},{"key":"BFmp2015206_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.psychres.2014.05.025","volume":"219","author":"Y Liu","year":"2014","unstructured":"Liu Y, Al-Sayegh H, Jabrah R, Wang W, Yan F, Zhang J . Association between C-reactive protein and depression: modulated by gender and mediated by body weight. Psychiatry Res 2014; 219: 103\u2013108.","journal-title":"Psychiatry Res"},{"key":"BFmp2015206_CR59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499\u2013511.","journal-title":"Circulation"},{"key":"BFmp2015206_CR60","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y . More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811\u2013818.","journal-title":"Stat Med"},{"key":"BFmp2015206_CR61","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41: 1149\u20131160.","journal-title":"Behav Res Methods"},{"key":"BFmp2015206_CR62","first-page":"00464","volume":"pii: S0006-3223","author":"NG Dowell","year":"2015","unstructured":"Dowell NG, Cooper EA, Tibble J, Voon V, Critchley HD, Cercignani M et al. Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue. Biol Psychiatry 2015; pii: S0006-3223: 00464\u201300473.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015206_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000111356","volume":"15","author":"A Schousboe","year":"1993","unstructured":"Schousboe A, Westergaard N, Sonnewald U, Petersen SB, Huang R, Peng L et al. Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev Neurosci 1993; 15: 359\u2013366.","journal-title":"Dev Neurosci"},{"key":"BFmp2015206_CR64","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000111347","volume":"15","author":"A Brand","year":"1993","unstructured":"Brand A, Richter-Landsberg C, Leibfritz D, Multinuclear NMR . studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289\u2013298.","journal-title":"Dev Neurosci"},{"key":"BFmp2015206_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","volume":"8","author":"L Chang","year":"2013","unstructured":"Chang L, Munsaka SM, Kraft-Terry S, Ernst T . Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol 2013; 8: 576\u2013593.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFmp2015206_CR66","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N Muller","year":"2007","unstructured":"Muller N, Schwarz MJ . The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007; 12: 988\u20131000.","journal-title":"Mol Psychiatry"},{"key":"BFmp2015206_CR67","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mp.2014.21","volume":"20","author":"C Nagy","year":"2014","unstructured":"Nagy C, Suderman M, Yang J, Szyf M, Mechawar N, Ernst C et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol Psychiatry 2014; 20: 320\u2013328.","journal-title":"Mol Psychiatry"},{"key":"BFmp2015206_CR68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","volume":"133","author":"D Piani","year":"1991","unstructured":"Piani D, Frei K, Do KQ, Cuenod M, Fontana A . Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991; 133: 159\u2013162.","journal-title":"Neurosci Lett"},{"key":"BFmp2015206_CR69","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1113\/jphysiol.2011.216978","volume":"589","author":"CJ Stagg","year":"2011","unstructured":"Stagg CJ, Bestmann S, Constantinescu AO, Moreno LM, Allman C, Mekle R et al. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol 2011; 589: 5845\u20135855.","journal-title":"J Physiol"},{"key":"BFmp2015206_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","volume":"31","author":"M Iwata","year":"2013","unstructured":"Iwata M, Ota KT, Duman RS . The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 2013; 31: 105\u2013114.","journal-title":"Brain Behav Immun"},{"key":"BFmp2015206_CR71","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR et al. Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 2013; 38: 2179\u20132187.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015206_CR72","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/npp.2014.141","volume":"39","author":"EG Vichaya","year":"2014","unstructured":"Vichaya EG, Hunt SC, Dantzer R . Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice. Neuropsychopharmacology 2014; 39: 2884\u20132890.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2015206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2015206","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2015206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:15:33Z","timestamp":1684433733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2015206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFmp2015206"],"URL":"https:\/\/doi.org\/10.1038\/mp.2015.206","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]},"assertion":[{"value":"26 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}